{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "inhibits_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O73683",
      "entity_text" : "Abeta",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:J3F2B0",
      "entity_text" : "Cas9",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Identifying the SAD risk factor FERMT2 as a modifier of both cellular phenotypes, the authors targeted FERMT2 with CRISPR / Cas9 mutagenesis, confirming that reducing its levels in neurons can decrease Abeta secretion and tau phosphorylation [XREF_BIBR].",
  "reading_complete" : "2020-08-08T19:18:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T19:05:43Z",
  "trigger" : "decrease",
  "evidence" : [ "Cas9 mutagenesis, confirming that reducing its levels in neurons can decrease Abeta secretion and tau phosphorylation" ],
  "pmc_id" : "6906186",
  "score" : 0
}